Novo Nordisk alleges fraud after $1.3 billion deal to buy hypertension drug from KBP Biosciences
Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...
Hosted on MSN11d
Florida Pharmaceutical Company To Pay $350,000 In Fraud Settlement
A Florida pharmaceutical company and its CEO have agreed to pay over $350,000 to the Florida Medicaid program as part of a ...
Mumbai: Leading Pharma Firm Duped Of ₹22.31 Crore In Sophisticated Cyber Scam; Case Registered
Mumbai: A leading Indian pharmaceutical company has fallen victim to a sophisticated cyber fraud, losing ₹22.31 crore in an elaborate email scam. The fraud was uncovered when the company’s finance ...
Business Wire1mon
REGN CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit On Behalf Of Regeneron Pharmaceuticals, Inc. Investors
Regeneron Pharmaceuticals, Inc., et al., Case No. 25-cv-145, on behalf of persons and entities that purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (“Regeneron” or the ...
Business Insider14d
Levi & Korsinsky Notifies Shareholders of Regeneron Pharmaceuticals, Inc. (REGN) of a Class Action Lawsuit and an Upcoming Deadline
THE LAWSUIT: A class action securities lawsuit was filed against Regeneron Pharmaceuticals, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud ...
Morningstar22d
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit
announces the filing of a class action lawsuit on behalf of purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates ...